WEST PHARMACEUTICAL SERVICES, INC. Proceeds from Other Equity
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Proceeds from Other Equity of $1.80 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-04-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromOtherEquity · last filed 2023-04-27
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from other equity for the quarter ending 2023-03-31 was $1.80M, a 10.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from other equity for the quarter ending 2022-03-31 was $2.00M, a 11.11% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from other equity for the quarter ending 2021-03-31 was $1.80M.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from other equity for fiscal 2022 was $7.30M, a 5.19% decline from fiscal 2021.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from other equity for fiscal 2021 was $7.70M, a 20.31% increase from fiscal 2020.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from other equity for fiscal 2020 was $6.40M, a 18.52% increase from fiscal 2019.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from other equity for fiscal 2019 was $5.40M, a 10.20% increase from fiscal 2018.
| Period end | Proceeds from Other Equity 3 month | Proceeds from Other Equity 12 month |
|---|---|---|
| 2023-03-31 | $1.80M 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $7.30M 10-K · filed 2023-02-21 | |
| 2022-03-31 | $2.00M 10-Q · filed 2023-04-27 | |
| 2021-12-31 | $7.70M 10-K · filed 2023-02-21 | |
| 2021-03-31 | $1.80M 10-Q · filed 2022-04-28 | |
| 2020-12-31 | $6.40M 10-K · filed 2023-02-21 | |
| 2019-12-31 | $5.40M 10-K · filed 2022-02-22 | |
| 2018-12-31 | $4.90M 10-K · filed 2021-02-23 | |
| 2017-12-31 | $4.40M 10-K · filed 2020-02-24 | |
| 2016-12-31 | $3.80M 10-K · filed 2019-02-28 | |
| 2015-12-31 | $3.20M 10-K · filed 2018-02-26 | |
| 2014-12-31 | $2.80M 10-K · filed 2017-02-28 | |
| 2013-12-31 | $2.50M 10-K · filed 2016-02-26 | |
| 2012-12-31 | $2.20M 10-K · filed 2015-02-25 | |
| 2011-12-31 | $1.90M 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |